Svenska
Svenska
News
News
Upcoming events
Subscribe
About us
About us
AlzeCure Pharma in brief
Mission, vision & strategy
A word from the CEO
Organization
Management team
Board of directors
Founders
Scientific advisors
Collaborations and Partnership
History
Career
Open positions
Research & development
Research & development
Project portfolio
NeuroRestore
Alzstatin
Alzheimer’s disease
Depression
Painless
ACD440
TrkA-NAM
Pain
Erythromelalgia
Small molecules
Publications
The patients story
Governance
Governance
Corporate Governance Reports
General meeting
General meetings
Nomination Committee
Board of directors
Management team
Remuneration
Auditors
Articles of association
Investors
Investors
Rights issue 2025
Capital Markets Day 2023
AlzeCure Pharma on First North Premier Growth Market
Certified Adviser
Prospectuses
The share
Trading information
Sharecapital development
Dividend policy
Ownership structure
Insiders
Analyst Coverage
Financial reports
Financial calendar
Presentations and Interviews
Press releases
Media
Media
Press releases
Presentations and Interviews
Video gallery
Image bank
Board of directors
Management
Founders
Logotype
Financial calendar
Subscribe
Contact
Subscribe
Contact
Contact
Office
Investors
Media
Search for:
Search
Press releases
Regulatory press releases
Other press releases
All pressreleases
2021
2025
2024
2023
2022
2020
2019
2018
All years
November 10, 2021
AlzeCure publishes its interim report for January – September 2021
August 25, 2021
AlzeCure publishes its interim report for January – June 2021
May 17, 2021
Report from the annual general meeting of AlzeCure Pharma on 17 May 2021
May 5, 2021
AlzeCure publishes its interim report for January – March 2021
April 19, 2021
AlzeCure announces positive data from clinical study with ACD440
April 6, 2021
AlzeCure Pharma publishes its Annual Report for 2020
February 26, 2021
AlzeCure publishes its Year-end report for 2020
